Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

391
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
391

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing salmon calcitonin for glioblastoma treatment: Targeting Yes-associated Protein (YAP)/ Transcriptional co‑activator with PDZ‑binding motif (TAZ) via hippo pathway activation.

Neuro-oncology advances·2026
Same author

A pilot study of magnetic resonance fingerprinting and radiomics analysis in autosomal dominant polycystic kidney disease.

Kidney international·2026
Same author

Oxidative stress, antioxidant depletion, and DNA damage in post-COVID-19 patients: evidence of a disrupted redox network and loss of age-dependent antioxidant compensation.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Entropy, Free Energy, and a Generalized Order Parameter for Liquid Crystal Phases of Chiral and Achiral Rods.

Journal of chemical theory and computation·2026
Same author

Comparative genomic and proteomic analysis reveals orthogroup structured evolution of tick protease inhibitors.

Comparative biochemistry and physiology. Part D, Genomics & proteomics·2026
Same author

Assessment of Circulating Cell Free DNA Methylation Biomarker of Panel of Selected Genes for Lung Cancer Detection.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Related Experiment Video

Updated: Dec 17, 2025

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

37.5K

Visualizing mitochondrial (dys)function using positron emission tomography imaging.

Anand Srivastava1, Pottumarthi V Prasad2

  • 1Division of Nephrology and Hypertension, Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Kidney International
|June 24, 2020
PubMed
Summary
This summary is machine-generated.

Assessing kidney mitochondrial dysfunction is crucial for understanding kidney disease. A novel positron emission tomography probe, 18F-BCPP-BF, effectively visualizes and quantifies kidney mitochondrial function in disease models.

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.4K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 17, 2025

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

37.5K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.4K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.0K

Area of Science:

  • Nephrology
  • Nuclear Medicine
  • Mitochondrial Biology

Background:

  • Mitochondrial dysfunction is implicated in kidney disease pathogenesis.
  • Current methods for assessing kidney mitochondrial function are limited.
  • Developing reliable assessment tools is essential for research and clinical practice.

Purpose of the Study:

  • To evaluate a novel positron emission tomography (PET) probe, 18F-BCPP-BF, for assessing kidney mitochondrial status.
  • To determine if PET imaging with 18F-BCPP-BF can detect mitochondrial dysfunction in animal models of kidney disease.

Main Methods:

  • Utilized positron emission tomography (PET) imaging in three distinct animal models of kidney disease.
  • Administered a novel PET tracer, 2-tert-butyl-4-chloro-5-[6-(4-18F-fluorobutoxy)-pyridin-3-ylmethoxy]-2H-pyridazin-3-one (18F-BCPP-BF).
  • Quantified the uptake of 18F-BCPP-BF in the kidneys to assess mitochondrial function.

Main Results:

  • Demonstrated that reduced uptake of 18F-BCPP-BF correlates with decreased mitochondrial function.
  • Successfully visualized kidney mitochondrial status using PET imaging.
  • Confirmed the probe's utility across multiple kidney disease models.

Conclusions:

  • 18F-BCPP-BF PET imaging is a viable method for assessing kidney mitochondrial function.
  • This novel approach can detect mitochondrial dysfunction relevant to kidney diseases.
  • Further research may translate this technique for clinical application in nephrology.